Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

BBH vs. IBBQ: which is better?

Bottom line

BBH vs IBBQ: the short answer

BBH (VanEck Biotech ETF) and IBBQ (Invesco Nasdaq Biotechnology ETF) share a meaningful slice of their top holdings — about 59% by weight.

But IBBQ is far broader, holding 261 positions to 25 for BBH, so beyond the top names it adds exposure BBH doesn't have.

IBBQ is cheaper at 0.19% vs 0.35% — a difference of $16 a year per $10,000 invested.

Over one year, BBH returned +21.2% vs −0.6% for IBBQ (reporting dates differ).

Updated Nov 19, 2026

BBH vs IBBQ side by side

BBHIBBQ
TypeETFETF
Fund familyVanEckInvesco
CategoryTechnology SectorTechnology Sector
Expense ratio0.35%0.19%
Annual cost per $10k$35$19
10-yr cost on $10k (prospectus)$443$242
Max front loadNoneNone
12b-1 fee——
1-yr return+21.2%−0.6%
5-yr return (annualized)+2.7%—
10-yr return (annualized)+4.5%—
Best quarter+27.6%+12.0%
Worst quarter−18.2%−11.7%
Net assets (fund)$395.6M$67.4M
Number of holdings25261
Portfolio turnover19%17%
Returns as ofDec 31, 2025Dec 31, 2024

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearBBHIBBQDifference
2024−4.4%−0.6%−3.8%
2023+3.9%+4.5%−0.6%
2022−15.1%−10.2%−4.9%

Source: Fund prospectus bar charts

Holdings overlap

14 of BBH's top 25 holdings also appear in IBBQ's top 25.

Shared top holdings
HoldingBBHIBBQ
Amgen Inc15.25%7.10%
Gilead Sciences Inc12.79%7.39%
Vertex Pharmaceuticals Inc9.10%7.38%
Regeneron Pharmaceuticals Inc6.21%5.08%
Revolution Medicines Inc5.27%2.48%
Argenx SE4.97%1.89%
Alnylam Pharmaceuticals Inc3.83%3.19%
Biogen Inc3.63%2.29%
Moderna Inc3.36%1.48%
Illumina Inc3.17%1.98%
United Therapeutics Corp2.83%1.94%
Insmed Inc2.67%1.83%
Incyte Corp2.49%1.53%
Neurocrine Biosciences Inc2.08%1.26%

Source: SEC Form N-PORT

BBH top 10

  1. Amgen Inc — 15.25%
  2. Gilead Sciences Inc — 12.79%
  3. Vertex Pharmaceuticals Inc — 9.10%
  4. Regeneron Pharmaceuticals Inc — 6.21%
  5. Revolution Medicines Inc — 5.27%
  6. Argenx SE — 4.97%
  7. Natera Inc — 4.92%
  8. IQVIA Holdings Inc — 4.31%
  9. Alnylam Pharmaceuticals Inc — 3.83%
  10. Biogen Inc — 3.63%

IBBQ top 10

  1. Invesco Private Prime Fund — 14.20%
  2. Gilead Sciences, Inc. — 7.39%
  3. Vertex Pharmaceuticals Inc. — 7.38%
  4. Amgen Inc. — 7.10%
  5. Invesco Private Government Fund — 5.48%
  6. Regeneron Pharmaceuticals, Inc. — 5.08%
  7. Alnylam Pharmaceuticals, Inc. — 3.19%
  8. Revolution Medicines, Inc. — 2.48%
  9. Biogen Inc. — 2.29%
  10. Illumina, Inc. — 1.98%

FAQ

What is the difference between BBH and IBBQ?
BBH (VanEck Biotech ETF) and IBBQ (Invesco Nasdaq Biotechnology ETF) share a meaningful slice of their top holdings — about 59% by weight. But IBBQ is far broader, holding 261 positions to 25 for BBH, so beyond the top names it adds exposure BBH doesn't have.
Which is cheaper, BBH or IBBQ?
IBBQ has the lower expense ratio (0.19%).
Should I own both BBH and IBBQ?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.